Document › Details
3P Biopharmaceuticals S.L.. (5/5/15). "Press Release: 3P Biopharmaceuticals Acquires a Mass Spectrometer".
|Organisation||3P Biopharmaceuticals S.L.|
|Organisation 2||Waters Corporation (NYSE: WAT)|
|Product||Xevo® G2-XS QTof mass spectrometer|
|Product 2||mass spectrometry-based analysis of biopharmaceutical|
|Index term||Infarco–Waters: mass spectrometer, 201505 supply acquisition of Xevo G2-XS QTof MS system by 3PBio|
We have recently added a mass spectrometer to our pipeline equipment: a device that allows the measurement of the internal mass of proteins and the determination of their peptide fingerprint, ensuring a deeper characterization of new processes.
This significant economic and technological investment is a very important qualitative leap for 3P since it will mean reaching adequate capacity for characterizing the structure of proteins developed in their processes.
In addition, this significant investment in technology, along with others that we will make in the next few months, sets us apart in terms of our internal capabilities. In maintaining control over our activities by keeping them on our own premises, we provide our clients a differential value in the development and production services we offer by minimizing outsourcing that result in increased costs and production time, and in a loss of control over processes and knowledge of molecules.
Record changed: 2016-06-07
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]